Print

Evotec AG (EVTG.F) Partners With Haplogen to Develop Drugs for Infectious Diseases  
11/15/2012 7:43:25 AM

HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases.
//-->